IKONISYS SA (ALIKO.PA) Stock Price, Forecast & Analysis

EPA:ALIKO • FR00140048X2

1.605 EUR
-0.02 (-0.93%)
Last: Feb 20, 2026, 07:00 PM

ALIKO.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap25.42M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares15.84M
Float5.85M
52 Week High1.84
52 Week Low1.28
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2021-07-19
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
ALIKO.PA short term performance overview.The bars show the price performance of ALIKO.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

ALIKO.PA long term performance overview.The bars show the price performance of ALIKO.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10

The current stock price of ALIKO.PA is 1.605 EUR. In the past month the price increased by 0.31%. In the past year, price increased by 14.64%.

IKONISYS SA / ALIKO Daily stock chart

ALIKO.PA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ALIKO.PA. When comparing the yearly performance of all stocks, ALIKO.PA is one of the better performing stocks in the market, outperforming 70.63% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
ALIKO.PA Full Technical Analysis Report

ALIKO.PA Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
ALIKO.PA financials

ALIKO.PA Forecast & Estimates

9 analysts have analysed ALIKO.PA and the average price target is 2.86 EUR. This implies a price increase of 77.94% is expected in the next year compared to the current price of 1.605.


Analysts
Analysts86.67
Price Target2.86 (78.19%)
EPS Next YN/A
Revenue Next YearN/A
ALIKO.PA Analyst EstimatesALIKO.PA Analyst Ratings

ALIKO.PA Ownership

Ownership
Inst Owners45.13%
Ins Owners2.22%
Short Float %N/A
Short RatioN/A
ALIKO.PA Ownership

ALIKO.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
1MDT MEDTRONIC PLC16.06108.279B
2M6 MEDTRONIC PLC15.75106.138B
SHL SIEMENS HEALTHINEERS AG15.5347.771B
PHIA KONINKLIJKE PHILIPS NV17.325.421B
PHI1 KONINKLIJKE PHILIPS NV17.3125.364B
BIM BIOMERIEUX18.9211.274B
DIA DIASORIN SPA17.173.929B
OBCK OTTOBOCK SE & CO KGAA18.143.644B
AFX CARL ZEISS MEDITEC AG - BR11.22.406B
1AFX CARL ZEISS MEDITEC AG - BR10.942.309B

About ALIKO.PA

Company Profile

ALIKO logo image Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.

Company Info

IKONISYS SA

62 Rue De Caumartin, Paris 9

Paris ILE-DE-FRANCE FR

Employees: 15

ALIKO Company Website

ALIKO Investor Relations

IKONISYS SA / ALIKO.PA FAQ

What does IKONISYS SA do?

Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 10 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.


Can you provide the latest stock price for IKONISYS SA?

The current stock price of ALIKO.PA is 1.605 EUR. The price decreased by -0.93% in the last trading session.


Does ALIKO stock pay dividends?

ALIKO.PA does not pay a dividend.


What is the ChartMill technical and fundamental rating of ALIKO stock?

ALIKO.PA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Where is IKONISYS SA (ALIKO.PA) stock traded?

ALIKO.PA stock is listed on the Euronext Paris exchange.


Can you provide the number of employees for IKONISYS SA?

IKONISYS SA (ALIKO.PA) currently has 15 employees.